Journal of Inherited Metabolic Disease

, Volume 8, Issue 3, pp 101–104

Amniotic tissue transplantation as a trial of treatment in some lysosomal storage diseases

  • A. Tylki-Szymańska
  • D. Maciejko
  • M. Kidawa
  • U. Jabłońska-Budaj
  • B. Czartoryska
Article

DOI: 10.1007/BF01819289

Cite this article as:
Tylki-Szymańska, A., Maciejko, D., Kidawa, M. et al. J Inherit Metab Dis (1985) 8: 101. doi:10.1007/BF01819289

Abstract

This communication reports the clinical and biochemical results in six patients: four with mucopolysaccharidosis, one with GM1 gangliosidosis (Morquio B) and one with I-cell disease, who were treated by amniotic tissue transplantation. The sole evident clinical result was the diminishing of corneal clouding in three cases. A slight increase of beta-galactosidase activity in one patient's plasma was observed. The time of improvement was about 2 months after the transplantation and was transitory.

Copyright information

© SSIEM and MTP Press Limited 1985

Authors and Affiliations

  • A. Tylki-Szymańska
    • 1
  • D. Maciejko
    • 1
  • M. Kidawa
    • 1
  • U. Jabłońska-Budaj
    • 1
  • B. Czartoryska
    • 2
  1. 1.Department of Metabolic DiseasesMemorial Hospital, Child Health CentreWarsawPoland
  2. 2.Department of GeneticsInstitute of PsychoneurologyWarsawPoland

Personalised recommendations